VANCOUVER, BC / ACCESS Newswire / April 7, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...
“Last year, unitary protection… was requested for about 28,000 patents granted by the EPO, representing slightly more than 25% of all EU patents issued in 2024.” On Tuesday, the European Patent Office ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results